01 1Synthon Pharmaceuticals
01 1TIVOZANIB HYDROCHLORIDE MONOHYDRATE
01 1Netherlands
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-10-09
Pay. Date : 2024-09-09
DMF Number : 40289
Submission : 2024-09-10
Status : Active
Type : II
20
Synthon Bv, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is TIVOZANIB HYDROCHLORIDE MONOHYDRATE, with a corresponding US DMF Number 40289.
Remarkably, this DMF maintains an Active status since its submission on September 10, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 09, 2024, and payment made on September 09, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
